Kimberly-Clark Corporation

Money Moves

Q1 2026 earnings beat estimates; maintaining 2026 outlook while restructuring supply chains to reduce tariff exposure

Three major US household-goods makers have now reported how the combined tariff and oil-cost shock hits their books. Kimberly-Clark beat Q1 estimates on April 28, with adjusted EPS of $1.97 against an expected $1.92, but still carries $300 million in tariff exposure representing about 20% of its US cost base. Colgate-Palmolive beat Q1 expectations on May 1 and immediately flipped its full-year gross margin guidance from expansion to decline, citing $300 million in higher raw-material and logistics costs from crude oil and tariffs.

Updated 4 days ago

Money Moves

Acquirer

Johnson & Johnson spun off its consumer health division as Kenvue in May 2023, creating the world's largest pure-play consumer health company. Less than three years later, shareholders of both Kimberly-Clark and Kenvue have overwhelmingly approved a $48.7 billion acquisition that will absorb Kenvue into the Kleenex and Huggies maker—with 96% of Kimberly-Clark shares and 99% of Kenvue shares voting in favor. On January 30, 2026, The Lancet published a comprehensive study finding no evidence linking acetaminophen use during pregnancy to autism, directly contradicting concerns raised by the Trump administration that had sent Kenvue's stock tumbling in late 2025.

Updated Feb 5